Clinical trial

Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With…

NCT00197444 · Hamamatsu University, Other · Completed

Key facts

NCT number NCT00197444
Title Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer
Official title A Phase II Study of Daily Low-Dose of Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum) and Continuous Infusion of 5-FU Combined With Radiation for the Treatment of Esophageal Cancer
Lead sponsor Hamamatsu University, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Esophageal Cancer, Squamous Cell Carcinoma
Intervention type Drug, Radiation
Interventions CDGP/5-FU combined with radiation, Radiotherapy
Enrollment 33
Start date Jan 1, 2003
Primary completion Sep 1, 2008
Completion Dec 1, 2008
First posted Sep 20, 2005
Last update posted Feb 20, 2009
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies